Tag: Nursing

Which clinical manifestation is caused by the accumulation of ammonia in patients diagnosed with cirrhosis?
Ascites
Esophageal varices
Hepatic encephalopathy syndrome
Hepatorenal syndrome

rotigotine how the medication works, patient education associated with the medication, the expected outcomes, and priority nursing related interventions for this specific medication.
How the medication works
Rotigotine is a non-ergoline dopamine agonist delivered via a transdermal patch (Neupro). It stimulates dopamine receptors (primarily D3, D2, and D1) in the central nervous system to help restore dopaminergic activity. It is used to treat symptoms of Parkinson disease and restless legs syndrome by reducing bradykinesia, rigidity, tremor, and motor fluctuations.
Route and formulation: continuous transdermal delivery provides steady plasma levels over 24 hours, which can reduce motor fluctuations associated with oral dosing.
Patient education
Application: apply one patch once daily to clean, dry, intact skin on the abdomen, thigh, hip, shoulder, or upper arm. Press firmly for ~30 seconds to ensure adhesion.
Rotation: rotate application sites; do not apply a patch to the same site for at least 14 days to reduce skin irritation.
Bathing/swimming: the patch is water-resistant, but avoid rubbing the patch; replace it if it comes off.
Removal: dispose of used patches safely (fold adhesive sides together) and keep out of reach of children and pets.
Timing and adherence: apply at about the same time each day; do not stop suddenly without consulting the prescriber—dose changes should be gradual.
Side effects to report: new or worsening drowsiness or sudden sleep episodes, confusion, hallucinations, severe dizziness, fainting, new compulsive behaviors (gambling, excessive shopping, hypersexuality), severe nausea or vomiting, or severe skin reactions at the application site.
Precautions: avoid alcohol and other CNS depressants until response is known; inform providers about the patch before MRI, diathermy, or other procedures that may require removal.
Interactions: tell the clinician about other dopaminergic or dopamine-blocking medications (e.g., antipsychotics) and antihypertensives.
Expected outcomes
Reduction in Parkinsonian motor symptoms: decreased tremor, rigidity, and bradykinesia; improved motor function and activities of daily living.
Reduction in restless legs symptoms for patients treated for RLS (decreased urge to move legs, improved sleep).
Improved overall mobility and decreased motor fluctuations when used as part of a prescribed regimen.
Monitoring goals: therapeutic benefit with tolerable side effects and no emergence of serious adverse events (e.g., severe orthostatic hypotension, psychosis, or impulse-control disorders).
Priority nursing related interventions
Baseline assessment: document Parkinson symptoms, baseline blood pressure (supine and standing), mental status, sleep patterns, skin condition at potential application sites, and current medications.
Monitor for adverse effects: assess for orthostatic hypotension, increased somnolence or sudden sleep episodes, hallucinations or confusion, nausea, dyskinesias, and signs of impulse-control disorders.
Fall risk mitigation: implement fall precautions for patients with dizziness, orthostatic changes, or sudden sleepiness; assist with ambulation as needed.
Skin assessment: inspect application site daily for irritation, erythema, or allergic reaction; rotate sites and document site changes.
Medication administration and adherence: teach correct patch application and disposal; verify daily use and check for patches missed or incorrectly applied.
Titration and discontinuation: monitor response during dose titration and educate that dose adjustments should be guided by prescriber; advise against abrupt discontinuation—coordinate gradual tapering to avoid withdrawal symptoms or sudden symptom worsening.
Coordinate care and education: communicate with prescriber about efficacy and adverse effects, educate patient and caregivers about warning signs that require urgent evaluation, and review potential drug interactions.
Pre-procedure instructions: ensure patch removal prior to MRI, diathermy, or cardioversion as directed by facility protocol, and document removal and reapplication timing.

Which of the following is NOT one of the four modifiable health risk behaviors?
Group of answer choices
A. smoking
B. lack of physical activity
C. socioeconomic class
D. poor nutrition

Which of the following are policies that can reduce the negative effects of low socioeconomic status on health outcomes?speed limitsparental-leave legislationdrinking age restrictions
speed limits
parental-leave legislation
drinking age restrictions

Which class of medication does not directly or indirectly reduce inflammation in patients with asthma?
Beta-2-agonists
Inhaled corticosteroids
Theophylline
Leukotriene receptor antagonists

Which of the following is a boundary (the B in ADOBE ) we discussed in class regarding difficult interactions with clients?
Time
Acknowledge Problems
Discover Meaning
Extend the system

what do you need to check before administering albuterol select all that apply
allergies
right medication
right time
right patient
right Route
right dose
check HR before administering

All of the following are examples of secondary prevention, except:
Group of answer choices
Mammogram
Immunizations
Pap Smears
Breast Cancer Screening
None of the above

Based on the routes of administration, the maximum bioavailabilty of a drug is achieved through:
Nasal administration
Rectal administration
Intravenous administration
Oral administration

A 40-year-old female with end-stage ovarian cancer undergoing chemotherapy complains of nausea, vomiting, abdominal distention, and abdominal pain. What should the oncology nurse do?